Scheduled Conference Call for Financial Results
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) has set an important date for investors and interested stakeholders. The company will host its third quarter 2024 financial results conference call and webcast on an upcoming Wednesday. This event is an opportunity for the company to share its financial performance and future outlook, providing transparency to its investors.
Conference Call Details
The conference call will take place at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time). Prior to this call, Neurocrine plans to issue a press release detailing its financial results at 4:00 a.m. PT (7:00 a.m. ET) on the same day. This structured timeline allows participants to digest the company’s performance before engaging in the discussion.
Dial-In Information
For those wishing to participate, there are specific phone numbers provided for both domestic and international callers. The domestic dial-in number is 800-225-9448, while international callers can use 203-518-9708. To ensure a smooth experience, make sure to reference the conference ID: NBIX during your call.
Accessing the Webcast
Investors and interested parties can also engage with the event through a live webcast, accessible via the Neurocrine Biosciences website under the Investors section. Following the live presentation, a replay will be available on the company’s site approximately an hour after the event concludes, and it will remain accessible for about a month.
About Neurocrine Biosciences
Neurocrine Biosciences operates with a clear mission: to alleviate suffering for individuals facing significant health challenges. This commitment drives the company to focus on developing innovative treatments for a variety of neurological, neuroendocrine, and neuropsychiatric conditions. Their portfolio features FDA-approved solutions addressing tardive dyskinesia, chorea associated with Huntington's disease, and more. The dedication spans over three decades, demonstrating the company’s long-standing expertise in neuroscience.
Innovative Pipeline and Commitment
Neurocrine’s diverse pipeline also showcases several compounds undergoing mid- to late-phase clinical development, targeting areas with limited treatment options. The company emphasizes the importance of their robust research endeavors, driven by a unique understanding of the complexities involved in brain and body interconnections. Their relentless pursuit of pioneering therapies signifies not just a business endeavor, but a compassionate approach to healthcare.
Engagement in the Community
The company actively invites community engagement and aims to keep stakeholders informed about its progress. Through its regular updates, Neurocrine ensures that investors are aware of all relevant developments, fostering a sense of connection and collaboration in its endeavors.
Frequently Asked Questions
What is the purpose of the upcoming conference call?
The conference call aims to discuss the financial results for the third quarter of 2024 and provide insight into future goals and strategies.
How can I access the live conference call?
You can participate in the conference call by dialing the respective domestic or international numbers, following the reference of the conference ID: NBIX.
Will the financial results be available online?
Yes, the financial results will be issued via a press release that is accessible on the Neurocrine Biosciences website prior to the call.
How long will the webcast replay be available?
The replay of the webcast will be available for about one month, allowing stakeholders to revisit the discussions.
Where can I find more information about Neurocrine Biosciences?
Additional information about Neurocrine's mission, product portfolio, and latest developments can be found on their official website.
